Cargando…
Impacts of the COVID‐19 pandemic on pharmaceuticals in wastewater treated for beneficial reuse: Two case studies in central Pennsylvania
During the COVID‐19 pandemic, wastewater surveillance was leveraged as a powerful tool for monitoring community‐scale health. Further, the well‐known persistence of some pharmaceuticals through wastewater treatment plants spurred concerns that increased usage of pharmaceuticals during the pandemic w...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538887/ https://www.ncbi.nlm.nih.gov/pubmed/35919971 http://dx.doi.org/10.1002/jeq2.20398 |
_version_ | 1784803405536952320 |
---|---|
author | Hayden, Kathryn R. Jones, Matthew Elkin, Kyle R. Shreve, Michael J. Clees, William Irvin Clark, Shirley Mashtare, Michael L. Veith, Tamie L. Elliott, Herschel A. Watson, John E. Silverman, Justin Richard, Thomas L. Read, Andrew F. Preisendanz, Heather E. |
author_facet | Hayden, Kathryn R. Jones, Matthew Elkin, Kyle R. Shreve, Michael J. Clees, William Irvin Clark, Shirley Mashtare, Michael L. Veith, Tamie L. Elliott, Herschel A. Watson, John E. Silverman, Justin Richard, Thomas L. Read, Andrew F. Preisendanz, Heather E. |
author_sort | Hayden, Kathryn R. |
collection | PubMed |
description | During the COVID‐19 pandemic, wastewater surveillance was leveraged as a powerful tool for monitoring community‐scale health. Further, the well‐known persistence of some pharmaceuticals through wastewater treatment plants spurred concerns that increased usage of pharmaceuticals during the pandemic would increase the concentrations in wastewater treatment plant effluent. We collected weekly influent and effluent samples from May 2020 through May 2021 from two wastewater treatment plants in central Pennsylvania, the Penn State Water Reclamation Facility and the University Area Joint Authority, that provide effluent for beneficial reuse, including for irrigation. Samples were analyzed for severe acute respiratory syndrome coronavirus 2 (influent only), two over‐the‐counter medicines (acetaminophen and naproxen), five antibiotics (ampicillin, doxycycline, ofloxacin, sulfamethoxazole, and trimethoprim), two therapeutic agents (remdesivir and dexamethasone), and hydroxychloroquine. Although there were no correlations between pharmaceutical and virus concentration, remdesivir detection occurred when the number of hospitalized patients with COVID‐19 increased, and dexamethasone detection co‐occurred with the presence of patients with COVID‐19 on ventilators. Additionally, Penn State decision‐making regarding instruction modes explained the temporal variation of influent pharmaceutical concentrations, with detection occurring primarily when students were on campus. Risk quotients calculated for pharmaceuticals with known effective and lethal concentrations at which 50% of a population is affected for fish, daphnia, and algae were generally low in the effluent; however, some acute risks from sulfamethoxazole were high when students returned to campus. Remdesivir and dexamethasone persisted through the wastewater treatment plants, thereby introducing novel pharmaceuticals directly to soils and surface water. These results highlight connections between human health and water quality and further demonstrate the broad utility of wastewater surveillance. |
format | Online Article Text |
id | pubmed-9538887 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95388872022-10-11 Impacts of the COVID‐19 pandemic on pharmaceuticals in wastewater treated for beneficial reuse: Two case studies in central Pennsylvania Hayden, Kathryn R. Jones, Matthew Elkin, Kyle R. Shreve, Michael J. Clees, William Irvin Clark, Shirley Mashtare, Michael L. Veith, Tamie L. Elliott, Herschel A. Watson, John E. Silverman, Justin Richard, Thomas L. Read, Andrew F. Preisendanz, Heather E. J Environ Qual TECHNICAL REPORTS During the COVID‐19 pandemic, wastewater surveillance was leveraged as a powerful tool for monitoring community‐scale health. Further, the well‐known persistence of some pharmaceuticals through wastewater treatment plants spurred concerns that increased usage of pharmaceuticals during the pandemic would increase the concentrations in wastewater treatment plant effluent. We collected weekly influent and effluent samples from May 2020 through May 2021 from two wastewater treatment plants in central Pennsylvania, the Penn State Water Reclamation Facility and the University Area Joint Authority, that provide effluent for beneficial reuse, including for irrigation. Samples were analyzed for severe acute respiratory syndrome coronavirus 2 (influent only), two over‐the‐counter medicines (acetaminophen and naproxen), five antibiotics (ampicillin, doxycycline, ofloxacin, sulfamethoxazole, and trimethoprim), two therapeutic agents (remdesivir and dexamethasone), and hydroxychloroquine. Although there were no correlations between pharmaceutical and virus concentration, remdesivir detection occurred when the number of hospitalized patients with COVID‐19 increased, and dexamethasone detection co‐occurred with the presence of patients with COVID‐19 on ventilators. Additionally, Penn State decision‐making regarding instruction modes explained the temporal variation of influent pharmaceutical concentrations, with detection occurring primarily when students were on campus. Risk quotients calculated for pharmaceuticals with known effective and lethal concentrations at which 50% of a population is affected for fish, daphnia, and algae were generally low in the effluent; however, some acute risks from sulfamethoxazole were high when students returned to campus. Remdesivir and dexamethasone persisted through the wastewater treatment plants, thereby introducing novel pharmaceuticals directly to soils and surface water. These results highlight connections between human health and water quality and further demonstrate the broad utility of wastewater surveillance. John Wiley and Sons Inc. 2022-09-05 2022 /pmc/articles/PMC9538887/ /pubmed/35919971 http://dx.doi.org/10.1002/jeq2.20398 Text en © 2022 The Authors. Journal of Environmental Quality published by Wiley Periodicals LLC on behalf of American Society of Agronomy, Crop Science Society of America, and Soil Science Society of America. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | TECHNICAL REPORTS Hayden, Kathryn R. Jones, Matthew Elkin, Kyle R. Shreve, Michael J. Clees, William Irvin Clark, Shirley Mashtare, Michael L. Veith, Tamie L. Elliott, Herschel A. Watson, John E. Silverman, Justin Richard, Thomas L. Read, Andrew F. Preisendanz, Heather E. Impacts of the COVID‐19 pandemic on pharmaceuticals in wastewater treated for beneficial reuse: Two case studies in central Pennsylvania |
title | Impacts of the COVID‐19 pandemic on pharmaceuticals in wastewater treated for beneficial reuse: Two case studies in central Pennsylvania |
title_full | Impacts of the COVID‐19 pandemic on pharmaceuticals in wastewater treated for beneficial reuse: Two case studies in central Pennsylvania |
title_fullStr | Impacts of the COVID‐19 pandemic on pharmaceuticals in wastewater treated for beneficial reuse: Two case studies in central Pennsylvania |
title_full_unstemmed | Impacts of the COVID‐19 pandemic on pharmaceuticals in wastewater treated for beneficial reuse: Two case studies in central Pennsylvania |
title_short | Impacts of the COVID‐19 pandemic on pharmaceuticals in wastewater treated for beneficial reuse: Two case studies in central Pennsylvania |
title_sort | impacts of the covid‐19 pandemic on pharmaceuticals in wastewater treated for beneficial reuse: two case studies in central pennsylvania |
topic | TECHNICAL REPORTS |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538887/ https://www.ncbi.nlm.nih.gov/pubmed/35919971 http://dx.doi.org/10.1002/jeq2.20398 |
work_keys_str_mv | AT haydenkathrynr impactsofthecovid19pandemiconpharmaceuticalsinwastewatertreatedforbeneficialreusetwocasestudiesincentralpennsylvania AT jonesmatthew impactsofthecovid19pandemiconpharmaceuticalsinwastewatertreatedforbeneficialreusetwocasestudiesincentralpennsylvania AT elkinkyler impactsofthecovid19pandemiconpharmaceuticalsinwastewatertreatedforbeneficialreusetwocasestudiesincentralpennsylvania AT shrevemichaelj impactsofthecovid19pandemiconpharmaceuticalsinwastewatertreatedforbeneficialreusetwocasestudiesincentralpennsylvania AT cleeswilliamirvin impactsofthecovid19pandemiconpharmaceuticalsinwastewatertreatedforbeneficialreusetwocasestudiesincentralpennsylvania AT clarkshirley impactsofthecovid19pandemiconpharmaceuticalsinwastewatertreatedforbeneficialreusetwocasestudiesincentralpennsylvania AT mashtaremichaell impactsofthecovid19pandemiconpharmaceuticalsinwastewatertreatedforbeneficialreusetwocasestudiesincentralpennsylvania AT veithtamiel impactsofthecovid19pandemiconpharmaceuticalsinwastewatertreatedforbeneficialreusetwocasestudiesincentralpennsylvania AT elliottherschela impactsofthecovid19pandemiconpharmaceuticalsinwastewatertreatedforbeneficialreusetwocasestudiesincentralpennsylvania AT watsonjohne impactsofthecovid19pandemiconpharmaceuticalsinwastewatertreatedforbeneficialreusetwocasestudiesincentralpennsylvania AT silvermanjustin impactsofthecovid19pandemiconpharmaceuticalsinwastewatertreatedforbeneficialreusetwocasestudiesincentralpennsylvania AT richardthomasl impactsofthecovid19pandemiconpharmaceuticalsinwastewatertreatedforbeneficialreusetwocasestudiesincentralpennsylvania AT readandrewf impactsofthecovid19pandemiconpharmaceuticalsinwastewatertreatedforbeneficialreusetwocasestudiesincentralpennsylvania AT preisendanzheathere impactsofthecovid19pandemiconpharmaceuticalsinwastewatertreatedforbeneficialreusetwocasestudiesincentralpennsylvania |